PT2752172T - Stents de polímero recuperáveis de esmagamento - Google Patents
Stents de polímero recuperáveis de esmagamento Download PDFInfo
- Publication number
- PT2752172T PT2752172T PT141627620T PT14162762T PT2752172T PT 2752172 T PT2752172 T PT 2752172T PT 141627620 T PT141627620 T PT 141627620T PT 14162762 T PT14162762 T PT 14162762T PT 2752172 T PT2752172 T PT 2752172T
- Authority
- PT
- Portugal
- Prior art keywords
- frame
- crown
- stent
- diameter
- ring
- Prior art date
Links
- 229920000642 polymer Polymers 0.000 title description 87
- 239000003550 marker Substances 0.000 claims description 43
- 229920001432 poly(L-lactide) Polymers 0.000 claims description 17
- JVTAAEKCZFNVCJ-REOHCLBHSA-N L-lactic acid Chemical compound C[C@H](O)C(O)=O JVTAAEKCZFNVCJ-REOHCLBHSA-N 0.000 claims description 15
- 239000000463 material Substances 0.000 description 76
- 238000002788 crimping Methods 0.000 description 53
- 206010017076 Fracture Diseases 0.000 description 50
- 229910052751 metal Inorganic materials 0.000 description 37
- 239000002184 metal Substances 0.000 description 37
- 238000000034 method Methods 0.000 description 34
- 238000013461 design Methods 0.000 description 29
- 230000002829 reductive effect Effects 0.000 description 28
- 238000011084 recovery Methods 0.000 description 26
- 238000007906 compression Methods 0.000 description 24
- 230000006835 compression Effects 0.000 description 24
- 238000005452 bending Methods 0.000 description 20
- 230000000694 effects Effects 0.000 description 19
- 238000011068 loading method Methods 0.000 description 19
- 230000008859 change Effects 0.000 description 17
- 230000008569 process Effects 0.000 description 17
- 230000015572 biosynthetic process Effects 0.000 description 16
- 230000009467 reduction Effects 0.000 description 16
- 238000011282 treatment Methods 0.000 description 16
- 208000031481 Pathologic Constriction Diseases 0.000 description 14
- 238000004519 manufacturing process Methods 0.000 description 14
- 230000036262 stenosis Effects 0.000 description 14
- 208000037804 stenosis Diseases 0.000 description 14
- 238000012360 testing method Methods 0.000 description 14
- 230000002093 peripheral effect Effects 0.000 description 13
- 238000001727 in vivo Methods 0.000 description 11
- 208000034827 Neointima Diseases 0.000 description 10
- 210000004204 blood vessel Anatomy 0.000 description 10
- 230000006870 function Effects 0.000 description 10
- 239000011248 coating agent Substances 0.000 description 8
- 238000000576 coating method Methods 0.000 description 8
- 239000003814 drug Substances 0.000 description 8
- 229940079593 drug Drugs 0.000 description 8
- 210000001105 femoral artery Anatomy 0.000 description 8
- 238000002513 implantation Methods 0.000 description 8
- 210000005259 peripheral blood Anatomy 0.000 description 8
- 239000011886 peripheral blood Substances 0.000 description 8
- 230000001684 chronic effect Effects 0.000 description 7
- 230000004048 modification Effects 0.000 description 7
- 238000012986 modification Methods 0.000 description 7
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 7
- 229910001000 nickel titanium Inorganic materials 0.000 description 7
- 239000002243 precursor Substances 0.000 description 7
- 210000001367 artery Anatomy 0.000 description 6
- 230000006399 behavior Effects 0.000 description 6
- 239000007943 implant Substances 0.000 description 6
- 238000012545 processing Methods 0.000 description 6
- 210000004351 coronary vessel Anatomy 0.000 description 5
- 230000007423 decrease Effects 0.000 description 5
- 238000006073 displacement reaction Methods 0.000 description 5
- 230000009477 glass transition Effects 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 230000001788 irregular Effects 0.000 description 5
- 230000036961 partial effect Effects 0.000 description 5
- 239000002861 polymer material Substances 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 230000002411 adverse Effects 0.000 description 4
- 229920002988 biodegradable polymer Polymers 0.000 description 4
- 239000004621 biodegradable polymer Substances 0.000 description 4
- 238000009826 distribution Methods 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 238000007373 indentation Methods 0.000 description 4
- 239000007769 metal material Substances 0.000 description 4
- 239000000178 monomer Substances 0.000 description 4
- 230000007935 neutral effect Effects 0.000 description 4
- 229920003023 plastic Polymers 0.000 description 4
- 239000004033 plastic Substances 0.000 description 4
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 4
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- 208000037803 restenosis Diseases 0.000 description 4
- 238000002399 angioplasty Methods 0.000 description 3
- 229920001400 block copolymer Polymers 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 238000005520 cutting process Methods 0.000 description 3
- 125000004122 cyclic group Chemical group 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 238000012938 design process Methods 0.000 description 3
- 230000002349 favourable effect Effects 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 238000003698 laser cutting Methods 0.000 description 3
- 230000003902 lesion Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 229910052717 sulfur Inorganic materials 0.000 description 3
- 229910052721 tungsten Inorganic materials 0.000 description 3
- 230000002792 vascular Effects 0.000 description 3
- 208000010392 Bone Fractures Diseases 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 229920002614 Polyether block amide Polymers 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000027455 binding Effects 0.000 description 2
- 238000009739 binding Methods 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 238000005336 cracking Methods 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000009977 dual effect Effects 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 238000001125 extrusion Methods 0.000 description 2
- 238000002594 fluoroscopy Methods 0.000 description 2
- 238000009432 framing Methods 0.000 description 2
- 239000001307 helium Substances 0.000 description 2
- 229910052734 helium Inorganic materials 0.000 description 2
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 238000003754 machining Methods 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 229910052697 platinum Inorganic materials 0.000 description 2
- 229920001434 poly(D-lactide) Polymers 0.000 description 2
- 229920001610 polycaprolactone Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 230000008467 tissue growth Effects 0.000 description 2
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 2
- 239000010937 tungsten Substances 0.000 description 2
- 238000010200 validation analysis Methods 0.000 description 2
- 210000005166 vasculature Anatomy 0.000 description 2
- 238000012800 visualization Methods 0.000 description 2
- 239000011800 void material Substances 0.000 description 2
- 230000003313 weakening effect Effects 0.000 description 2
- VPVXHAANQNHFSF-UHFFFAOYSA-N 1,4-dioxan-2-one Chemical compound O=C1COCCO1 VPVXHAANQNHFSF-UHFFFAOYSA-N 0.000 description 1
- 125000003821 2-(trimethylsilyl)ethoxymethyl group Chemical group [H]C([H])([H])[Si](C([H])([H])[H])(C([H])([H])[H])C([H])([H])C(OC([H])([H])[*])([H])[H] 0.000 description 1
- RBMHUYBJIYNRLY-UHFFFAOYSA-N 2-[(1-carboxy-1-hydroxyethyl)-hydroxyphosphoryl]-2-hydroxypropanoic acid Chemical compound OC(=O)C(O)(C)P(O)(=O)C(C)(O)C(O)=O RBMHUYBJIYNRLY-UHFFFAOYSA-N 0.000 description 1
- OGYSYXDNLPNNPW-UHFFFAOYSA-N 4-butoxy-4-oxobutanoic acid Chemical compound CCCCOC(=O)CCC(O)=O OGYSYXDNLPNNPW-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 229910052770 Uranium Inorganic materials 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001028 anti-proliverative effect Effects 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229920013641 bioerodible polymer Polymers 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 238000000071 blow moulding Methods 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 238000010894 electron beam technology Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000004836 empirical method Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 210000003709 heart valve Anatomy 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 210000003090 iliac artery Anatomy 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 229910052741 iridium Inorganic materials 0.000 description 1
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 238000009740 moulding (composite fabrication) Methods 0.000 description 1
- 238000012014 optical coherence tomography Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008380 pattern binding Effects 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 238000013310 pig model Methods 0.000 description 1
- 239000004632 polycaprolactone Substances 0.000 description 1
- 229920002959 polymer blend Polymers 0.000 description 1
- 210000003137 popliteal artery Anatomy 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000000135 prohibitive effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 229920005604 random copolymer Polymers 0.000 description 1
- 239000003507 refrigerant Substances 0.000 description 1
- 210000002254 renal artery Anatomy 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000004626 scanning electron microscopy Methods 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 210000003270 subclavian artery Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- YFHICDDUDORKJB-UHFFFAOYSA-N trimethylene carbonate Chemical compound O=C1OCCCO1 YFHICDDUDORKJB-UHFFFAOYSA-N 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
- 230000008728 vascular permeability Effects 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 239000003190 viscoelastic substance Substances 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 229910052727 yttrium Inorganic materials 0.000 description 1
- PAPBSGBWRJIAAV-UHFFFAOYSA-N ε-Caprolactone Chemical class O=C1CCCCCO1 PAPBSGBWRJIAAV-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
- A61F2/958—Inflatable balloons for placing stents or stent-grafts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/06—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/9155—Adjacent bands being connected to each other
- A61F2002/91575—Adjacent bands being connected to each other connected peak to trough
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0076—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof multilayered, e.g. laminated structures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/0096—Markers and sensors for detecting a position or changes of a position of an implant, e.g. RF sensors, ultrasound markers
- A61F2250/0098—Markers and sensors for detecting a position or changes of a position of an implant, e.g. RF sensors, ultrasound markers radio-opaque, e.g. radio-opaque markers
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Cardiology (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Prostheses (AREA)
- Materials For Medical Uses (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Graft Or Block Polymers (AREA)
- Dental Preparations (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29996810P | 2010-01-30 | 2010-01-30 | |
| US38589510P | 2010-09-23 | 2010-09-23 | |
| US38589110P | 2010-09-23 | 2010-09-23 | |
| US38590210P | 2010-09-23 | 2010-09-23 | |
| US13/015,474 US8808353B2 (en) | 2010-01-30 | 2011-01-27 | Crush recoverable polymer scaffolds having a low crossing profile |
| US13/015,488 US8568471B2 (en) | 2010-01-30 | 2011-01-27 | Crush recoverable polymer scaffolds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2752172T true PT2752172T (pt) | 2016-09-06 |
Family
ID=48625656
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT141627620T PT2752172T (pt) | 2010-01-30 | 2011-01-28 | Stents de polímero recuperáveis de esmagamento |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP2752173B1 (https=) |
| JP (5) | JP5914938B2 (https=) |
| CN (2) | CN104739551B (https=) |
| DK (1) | DK2752172T3 (https=) |
| ES (1) | ES2589138T3 (https=) |
| HK (1) | HK1197171A1 (https=) |
| HR (1) | HRP20161044T1 (https=) |
| HU (1) | HUE030361T2 (https=) |
| PL (1) | PL2752172T3 (https=) |
| PT (1) | PT2752172T (https=) |
| RS (1) | RS55103B1 (https=) |
| SI (1) | SI2752172T1 (https=) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070156230A1 (en) | 2006-01-04 | 2007-07-05 | Dugan Stephen R | Stents with radiopaque markers |
| JP2014226353A (ja) * | 2013-05-23 | 2014-12-08 | ニプロ株式会社 | ステント |
| US9999527B2 (en) * | 2015-02-11 | 2018-06-19 | Abbott Cardiovascular Systems Inc. | Scaffolds having radiopaque markers |
| US9700443B2 (en) | 2015-06-12 | 2017-07-11 | Abbott Cardiovascular Systems Inc. | Methods for attaching a radiopaque marker to a scaffold |
| US20170105856A1 (en) * | 2015-10-16 | 2017-04-20 | Abbott Cardiovascular Systems Inc. | Non-circular radiopaque markers and methods for attaching a marker to a scaffold |
| JP7059182B2 (ja) * | 2015-12-17 | 2022-04-25 | アボット カーディオヴァスキュラー システムズ インコーポレイテッド | 薄肉スキャフォールド |
| KR101910952B1 (ko) * | 2016-10-28 | 2018-10-23 | 주식회사 넥스트바이오메디컬 | 압착 후 스텐트 지름을 산출하는 방법 |
| EP4732889A2 (en) | 2017-06-07 | 2026-04-29 | Supira Medical, Inc. | Intravascular fluid movement devices, systems, and methods of use |
| JP7319266B2 (ja) | 2017-11-13 | 2023-08-01 | シファメド・ホールディングス・エルエルシー | 血管内流体移動デバイス、システム、および使用方法 |
| EP4085965A1 (en) | 2018-02-01 | 2022-11-09 | Shifamed Holdings, LLC | Intravascular blood pumps and methods of use and manufacture |
| US12161857B2 (en) | 2018-07-31 | 2024-12-10 | Shifamed Holdings, Llc | Intravascular blood pumps and methods of use |
| US10449073B1 (en) * | 2018-09-18 | 2019-10-22 | Vesper Medical, Inc. | Rotary handle stent delivery system and method |
| JP2021192648A (ja) * | 2018-09-20 | 2021-12-23 | テルモ株式会社 | スキャホールドシステムおよびスキャホールドの載置方法 |
| CN109210361B (zh) * | 2018-09-29 | 2021-09-03 | 中山大学 | 一种二维负泊松比结构 |
| WO2020073047A1 (en) | 2018-10-05 | 2020-04-09 | Shifamed Holdings, Llc | Intravascular blood pumps and methods of use |
| EP3996797A4 (en) | 2019-07-12 | 2023-08-02 | Shifamed Holdings, LLC | INTRAVASCULAR BLOOD PUMPS AND METHOD OF USE AND METHOD OF MAKING |
| US11654275B2 (en) | 2019-07-22 | 2023-05-23 | Shifamed Holdings, Llc | Intravascular blood pumps with struts and methods of use and manufacture |
| EP4010046A4 (en) | 2019-08-07 | 2023-08-30 | Calomeni, Michael | Catheter blood pumps and collapsible pump housings |
| EP4034192B1 (en) | 2019-09-25 | 2025-12-24 | Supira Medical, Inc. | Intravascular blood pump systems and methods of use and control thereof |
| US12102815B2 (en) | 2019-09-25 | 2024-10-01 | Shifamed Holdings, Llc | Catheter blood pumps and collapsible pump housings |
| US12121713B2 (en) | 2019-09-25 | 2024-10-22 | Shifamed Holdings, Llc | Catheter blood pumps and collapsible blood conduits |
| US12521259B2 (en) | 2019-11-04 | 2026-01-13 | Reflow Medical, Inc. | Stents having protruding features for anchoring |
| EP4072650A4 (en) | 2019-12-11 | 2024-01-10 | Shifamed Holdings, LLC | Descending aorta and vena cava blood pumps |
| WO2021127503A1 (en) | 2019-12-19 | 2021-06-24 | Shifamed Holdings, Llc | Intravascular blood pumps, motors, and fluid control |
| CN111067679A (zh) * | 2020-03-02 | 2020-04-28 | 南京浩衍鼎业科技技术有限公司 | 一种具有高支撑强度的颅内可降解聚酯支架 |
| WO2021192636A1 (ja) * | 2020-03-27 | 2021-09-30 | テルモ株式会社 | 生体内留置用ステントおよびステントデリバリーシステム |
| NZ786736A (en) * | 2020-08-12 | 2022-07-29 | Yasuhiro Shobayashi | Stent |
| KR102357704B1 (ko) * | 2021-03-30 | 2022-02-08 | 성균관대학교산학협력단 | 제로 포아송비 구조체 및 이 구조체가 평면에 행렬 배열된 제로 포아송비의 평면 구조체 |
| CN114259609B (zh) * | 2021-12-28 | 2023-02-28 | 埃恩普裕(北京)科技有限公司 | 一种支架 |
| DE102024126582A1 (de) * | 2024-09-16 | 2026-03-19 | Universität Stuttgart, Körperschaft Des Öffentlichen Rechts | Medizinische Vorrichtung zur Behandlung von Blutgefäßerkrankungen, insbesondere endovaskuläres Implantat, sowie Herstellungsverfahren |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2079417C (en) | 1991-10-28 | 2003-01-07 | Lilip Lau | Expandable stents and method of making same |
| US5925061A (en) * | 1997-01-13 | 1999-07-20 | Gore Enterprise Holdings, Inc. | Low profile vascular stent |
| KR20010082497A (ko) * | 1997-09-24 | 2001-08-30 | 메드 인스티튜트, 인코포레이티드 | 반경방향으로 팽창가능한 스텐트 |
| US6758859B1 (en) * | 2000-10-30 | 2004-07-06 | Kenny L. Dang | Increased drug-loading and reduced stress drug delivery device |
| US20040176837A1 (en) * | 2001-05-17 | 2004-09-09 | Atladottir Svava Maria | Self-expanding stent and catheter assembly and method for treating bifurcations |
| DE10342758A1 (de) * | 2003-09-16 | 2005-04-28 | Campus Gmbh & Co Kg | Vorrichtung zum Einführen in Körperorgane mit Markierung der Lagekontrolle |
| CN1960684B (zh) * | 2004-04-02 | 2013-11-06 | 动脉再塑技术公司 | 基于聚合物的支架装置 |
| US8597716B2 (en) * | 2009-06-23 | 2013-12-03 | Abbott Cardiovascular Systems Inc. | Methods to increase fracture resistance of a drug-eluting medical device |
| US7731890B2 (en) * | 2006-06-15 | 2010-06-08 | Advanced Cardiovascular Systems, Inc. | Methods of fabricating stents with enhanced fracture toughness |
| US7947207B2 (en) * | 2005-04-12 | 2011-05-24 | Abbott Cardiovascular Systems Inc. | Method for retaining a vascular stent on a catheter |
| US7743481B2 (en) * | 2005-04-29 | 2010-06-29 | Arterial Remodelling Technologies, Inc. | Stent crimping |
| US20060271170A1 (en) * | 2005-05-31 | 2006-11-30 | Gale David C | Stent with flexible sections in high strain regions |
| US20070156230A1 (en) | 2006-01-04 | 2007-07-05 | Dugan Stephen R | Stents with radiopaque markers |
| CN2885177Y (zh) * | 2006-01-28 | 2007-04-04 | 江阴法尔胜佩尔新材料科技有限公司 | 高径向支持力、轴向柔软、低剖面率冠状动脉支架 |
| US20070191926A1 (en) * | 2006-02-14 | 2007-08-16 | Advanced Cardiovascular Systems, Inc. | Stent pattern for high stent retention |
| WO2007146021A2 (en) * | 2006-06-06 | 2007-12-21 | Cook Incorporated | Stent with a crush-resistant zone |
| US20080033523A1 (en) * | 2006-07-10 | 2008-02-07 | Gale David C | Stent crack reduction |
| US20080021546A1 (en) * | 2006-07-18 | 2008-01-24 | Tim Patz | System for deploying balloon-expandable heart valves |
| US8002817B2 (en) * | 2007-05-04 | 2011-08-23 | Abbott Cardiovascular Systems Inc. | Stents with high radial strength and methods of manufacturing same |
| US8388673B2 (en) * | 2008-05-02 | 2013-03-05 | Abbott Cardiovascular Systems Inc. | Polymeric stent |
| US20090105797A1 (en) * | 2007-10-18 | 2009-04-23 | Med Institute, Inc. | Expandable stent |
| JP5243023B2 (ja) * | 2007-12-28 | 2013-07-24 | テルモ株式会社 | 生体内留置用ステントおよび生体器官拡張器具 |
| WO2009121048A1 (en) * | 2008-03-28 | 2009-10-01 | Ethicon, Inc. | Method of manufacturing a polymeric stent having a circumferential ring configuration |
| US20100198330A1 (en) * | 2009-02-02 | 2010-08-05 | Hossainy Syed F A | Bioabsorbable Stent And Treatment That Elicits Time-Varying Host-Material Response |
| US20100292777A1 (en) * | 2009-05-13 | 2010-11-18 | Boston Scientific Scimed, Inc. | Stent |
-
2011
- 2011-01-28 CN CN201510098377.XA patent/CN104739551B/zh active Active
- 2011-01-28 SI SI201130906A patent/SI2752172T1/sl unknown
- 2011-01-28 PL PL14162762.0T patent/PL2752172T3/pl unknown
- 2011-01-28 ES ES14162762.0T patent/ES2589138T3/es active Active
- 2011-01-28 PT PT141627620T patent/PT2752172T/pt unknown
- 2011-01-28 DK DK14162762.0T patent/DK2752172T3/en active
- 2011-01-28 EP EP14162936.0A patent/EP2752173B1/en not_active Not-in-force
- 2011-01-28 RS RS20160728A patent/RS55103B1/sr unknown
- 2011-01-28 CN CN201510098834.5A patent/CN104739553B/zh active Active
- 2011-01-28 HU HUE14162762A patent/HUE030361T2/en unknown
- 2011-01-28 JP JP2012551349A patent/JP5914938B2/ja active Active
-
2014
- 2014-10-24 HK HK14110679.1A patent/HK1197171A1/en unknown
-
2015
- 2015-02-10 JP JP2015024348A patent/JP6366106B2/ja active Active
- 2015-02-10 JP JP2015024351A patent/JP6108242B2/ja not_active Expired - Fee Related
-
2016
- 2016-08-18 HR HRP20161044TT patent/HRP20161044T1/hr unknown
- 2016-12-14 JP JP2016242352A patent/JP6382285B2/ja active Active
-
2018
- 2018-08-01 JP JP2018145257A patent/JP2018196748A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN104739553A (zh) | 2015-07-01 |
| CN104739551A (zh) | 2015-07-01 |
| PL2752172T3 (pl) | 2016-12-30 |
| JP6382285B2 (ja) | 2018-08-29 |
| HK1196243A1 (en) | 2014-12-12 |
| JP5914938B2 (ja) | 2016-05-11 |
| JP2017080442A (ja) | 2017-05-18 |
| ES2589138T3 (es) | 2016-11-10 |
| EP2752173A1 (en) | 2014-07-09 |
| CN104739551B (zh) | 2017-07-04 |
| JP6366106B2 (ja) | 2018-08-01 |
| CN104739553B (zh) | 2018-01-12 |
| SI2752172T1 (sl) | 2016-10-28 |
| JP2015120002A (ja) | 2015-07-02 |
| DK2752172T3 (en) | 2016-10-03 |
| HRP20161044T1 (hr) | 2016-10-21 |
| JP2015128610A (ja) | 2015-07-16 |
| JP6108242B2 (ja) | 2017-04-05 |
| HUE030361T2 (en) | 2017-05-29 |
| JP2018196748A (ja) | 2018-12-13 |
| RS55103B1 (sr) | 2016-12-30 |
| HK1197171A1 (en) | 2015-01-09 |
| JP2013517913A (ja) | 2013-05-20 |
| EP2752173B1 (en) | 2018-04-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20220226133A1 (en) | Balloon expanded polymer stent | |
| PT2752172T (pt) | Stents de polímero recuperáveis de esmagamento | |
| US9827119B2 (en) | Polymer scaffolds having a low crossing profile | |
| JP6344727B2 (ja) | 圧潰復元可能なポリマースキャフォールドの作製方法 | |
| HK1196243B (en) | Crush recoverable polymer stents |